• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Novavax (NVAX)

Common Shares
Sell: $9.99|Buy: $10.13|Change: 0.39 (-3.72%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly ownedSwedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Thecompany manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Address

21 Firstfield Road
Gaithersburg
MD
USA
20878

Telephone

+1 240 2682000

Website

https://www.novavax.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Novavax Inc Second Quarter Earnings Conference Call for 20272027-08-06T08:30:00
Novavax Inc Second Quarter Earnings Results for 20272027-08-06T00:00:00
Novavax Inc Annual General Meeting for 20272027-06-18T08:30:00
Novavax Inc First Quarter Earnings Conference Call for 20272027-05-06T08:30:00
Novavax Inc First Quarter Earnings Results for 20272027-05-06T00:00:00
Novavax Inc Fourth Quarter Earnings Conference Call for 20262027-02-26T08:30:00
Novavax Inc Fourth Quarter Earnings Results for 20262027-02-26T00:00:00
Novavax Inc Annual Report for 20262027-02-26T00:00:00
Novavax Inc Third Quarter Earnings Conference Call for 20262026-11-05T08:30:00
Novavax Inc Third Quarter Earnings Result for 20262026-11-05T00:00:00

Previous key dates

NameKey Date
Citi's 2026 BioPharma Back to School Conference2026-09-10T10:00:00
2026 Cantor Global Healthcare Conference2026-09-09T09:45:00
Novavax Inc Second Quarter Earnings Conference Call for 20262026-08-06T08:30:00
Novavax Inc Second Quarter Earnings Result for 20262026-08-06T00:00:00
Novavax Inc Annual General Meeting for 20262026-06-18T08:30:00
2026 Jefferies Global Healthcare Conference2026-06-04T10:30:00
Novavax Inc First Quarter Earnings Conference Call for 20262026-05-06T08:30:00
Novavax Inc First Quarter Earnings Results for 20262026-05-06T00:00:00
Leerink Partners 2026 Global Healthcare Conference2026-03-10T15:40:00
TD Cowen 46th Annual Health Care Conference:2026-03-03T14:30:00
Novavax Inc Fourth Quarter Earnings Conference Call for 20252026-02-26T08:30:00
Novavax Inc Fourth Quarter Earnings Result for 20252026-02-26T00:00:00
Novavax Inc Annual Report for 20252026-02-26T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-14T16:30:00
Jefferies London Healthcare Conference2025-11-19T16:30:00
Novavax Inc Third Quarter Earnings Conference Call for 20252025-11-06T08:30:00
Novavax Inc Third Quarter Earnings Result for 20252025-11-06T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.